$YYAI
Connexa Sports Technologies Inc.

2024 Q1 Form 10-Q Financial Statement

#000149315224008851 Filed on March 05, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q1
Revenue $2.070M $1.606M
YoY Change 28.88% -61.78%
Cost Of Revenue $776.8K $536.0K
YoY Change 44.95% -83.43%
Gross Profit $1.293M $1.070M
YoY Change 20.83% 10.6%
Gross Profit Margin 62.46% 66.62%
Selling, General & Admin $3.486M $2.107M
YoY Change 65.46% -45.46%
% of Gross Profit 269.65% 196.93%
Research & Development $3.638K
YoY Change -98.68%
% of Gross Profit 0.34%
Depreciation & Amortization -$648.4K
YoY Change -814.14%
% of Gross Profit -60.61%
Operating Expenses $3.486M $2.110M
YoY Change 65.17% -49.01%
Operating Profit -$2.193M -$1.041M
YoY Change 110.75% -67.19%
Interest Expense -$5.516M
YoY Change -195.92%
% of Operating Profit
Other Income/Expense, Net -$1.580M -$5.790M
YoY Change -72.72% 110.55%
Pretax Income -$3.773M -$6.831M
YoY Change -44.77% 188.2%
Income Tax
% Of Pretax Income
Net Earnings -$3.773M -$48.88M
YoY Change -92.28% 1962.33%
Net Earnings / Revenue -182.29% -3043.98%
Basic Earnings Per Share $14.29 -$3.68
Diluted Earnings Per Share $14.29 -$3.68
COMMON SHARES
Basic Shares Outstanding 912.1K shares 13.27M shares
Diluted Shares Outstanding 912.1K shares 331.6K shares

Balance Sheet

Concept 2024 Q1 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $316.8K
YoY Change -70.74%
Cash & Equivalents $17.19M $316.8K
Short-Term Investments
Other Short-Term Assets $1.128M
YoY Change -39.95%
Inventory $1.331M $3.966M
Prepaid Expenses
Receivables $336.1K $531.8K
Other Receivables $0.00
Total Short-Term Assets $19.74M $5.942M
YoY Change 232.26% -60.89%
LONG-TERM ASSETS
Property, Plant & Equipment $15.77K
YoY Change
Goodwill $6.781M
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $0.00
YoY Change
Total Long-Term Assets $2.001M $13.57M
YoY Change -85.25% 294.33%
TOTAL ASSETS
Total Short-Term Assets $19.74M $5.942M
Total Long-Term Assets $2.001M $13.57M
Total Assets $21.75M $19.51M
YoY Change 11.47% 4.69%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.704M $3.881M
YoY Change -4.56% -51.13%
Accrued Expenses $3.280M $5.441M
YoY Change -39.71% 120.96%
Deferred Revenue
YoY Change
Short-Term Debt $347.5K
YoY Change -82.62%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $16.46M $29.26M
YoY Change -43.76% 1.15%
LONG-TERM LIABILITIES
Long-Term Debt $1.953M
YoY Change
Other Long-Term Liabilities $0.00
YoY Change
Total Long-Term Liabilities $1.245M $1.953M
YoY Change -36.28%
TOTAL LIABILITIES
Total Short-Term Liabilities $16.46M $29.26M
Total Long-Term Liabilities $1.245M $1.953M
Total Liabilities $17.70M $31.21M
YoY Change -43.29% 7.9%
SHAREHOLDERS EQUITY
Retained Earnings -$154.6M -$144.8M
YoY Change 6.8%
Common Stock $158.5M $132.8M
YoY Change 19.33%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $4.045M -$11.70M
YoY Change
Total Liabilities & Shareholders Equity $21.75M $19.51M
YoY Change 11.47% 4.69%

Cashflow Statement

Concept 2024 Q1 2023 Q1
OPERATING ACTIVITIES
Net Income -$3.773M -$48.88M
YoY Change -92.28% 1962.33%
Depreciation, Depletion And Amortization -$648.4K
YoY Change -814.14%
Cash From Operating Activities -$349.2K
YoY Change -80.42%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change -100.0%
Cash From Investing Activities $0.00
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.137M
YoY Change -43.17%
NET CHANGE
Cash From Operating Activities -349.2K
Cash From Investing Activities 0.000
Cash From Financing Activities 1.137M
Net Change In Cash 787.5K
YoY Change -224.27%
FREE CASH FLOW
Cash From Operating Activities -$349.2K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--04-30
dei Entity Central Index Key
EntityCentralIndexKey
0001674440
dei Entity Address State Or Province
EntityAddressStateOrProvince
MD
CY2024Q1 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
usd
CY2024Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
usd
CY2024Q1 CNXA Loss On Conversion Of Accounts Payable To Common Stock
LossOnConversionOfAccountsPayableToCommonStock
usd
CY2023Q1 CNXA Loss On Conversion Of Accounts Payable To Common Stock
LossOnConversionOfAccountsPayableToCommonStock
usd
us-gaap Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax
usd
CY2024Q1 us-gaap Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax
usd
us-gaap Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax
DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax
usd
CY2024Q1 us-gaap Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax
DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax
usd
us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
usd
CY2024Q1 us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
CY2024Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
CY2024Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
CY2022Q3 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
usd
CY2022Q4 CNXA Stock Issued During Period Cashless Exercise Of Warrants Value
StockIssuedDuringPeriodCashlessExerciseOfWarrantsValue
usd
CY2022Q4 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
usd
CY2022Q4 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
usd
CY2023Q1 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
usd
CY2023Q3 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
usd
CY2023Q3 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
usd
CY2023Q3 CNXA Stock Issued During Period Cashless Exercise Of Warrants Value
StockIssuedDuringPeriodCashlessExerciseOfWarrantsValue
usd
CY2023Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
usd
CY2023Q4 CNXA Stock Issued During Period Value Fractional Adjustment In Reverse Split
StockIssuedDuringPeriodValueFractionalAdjustmentInReverseSplit
usd
CY2023Q4 CNXA Stock Issued During Period Cashless Exercise Of Warrants Value
StockIssuedDuringPeriodCashlessExerciseOfWarrantsValue
usd
CY2024Q1 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
usd
CY2024Q1 CNXA Stock Issued During Period Cashless Exercise Of Warrants Value
StockIssuedDuringPeriodCashlessExerciseOfWarrantsValue
usd
us-gaap Share Based Compensation
ShareBasedCompensation
usd
us-gaap Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
usd
CNXA Noncash Transaction Costs
NoncashTransactionCosts
usd
CNXA Settlement Expense
SettlementExpense
usd
CNXA Loss On Settlement Of Accounts Payable
LossOnSettlementOfAccountsPayable
usd
us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CNXA Conversion Of Convertible Notes Payable And Accrued Interest To Common Stock
ConversionOfConvertibleNotesPayableAndAccruedInterestToCommonStock
usd
CNXA Warrants Granted For Deferred Compensation
WarrantsGrantedForDeferredCompensation
usd
CNXA Derivative Liability Recorded For Shares And Warrants Issued In Private Placement
DerivativeLiabilityRecordedForSharesAndWarrantsIssuedInPrivatePlacement
usd
CNXA Note Receivable Issued In Sale Of Playsight
NoteReceivableIssuedInSaleOfPlaysight
usd
CNXA Disposal Group Including Discontinued Operation Other Income Loss
DisposalGroupIncludingDiscontinuedOperationOtherIncomeLoss
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-01-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
01-41423
dei Entity Registrant Name
EntityRegistrantName
CONNEXA SPORTS TECHNOLOGIES INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
61-1789640
dei Entity Address Address Line1
EntityAddressAddressLine1
2709 NORTH ROLLING ROAD
dei Entity Address Address Line2
EntityAddressAddressLine2
SUITE 138
dei Entity Address City Or Town
EntityAddressCityOrTown
WINDSOR MILL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
21244
dei City Area Code
CityAreaCode
(443)
dei Local Phone Number
LocalPhoneNumber
407-7564
dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value
dei Trading Symbol
TradingSymbol
CNXA
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
22172447 shares
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
17192733 usd
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
202095 usd
CY2024Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
336100 usd
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
399680 usd
CY2024Q1 us-gaap Inventory Net
InventoryNet
1331011 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
3189766 usd
CY2024Q1 CNXA Prepaid Inventory Current
PrepaidInventoryCurrent
640313 usd
CY2023Q2 CNXA Prepaid Inventory Current
PrepaidInventoryCurrent
936939 usd
CY2024Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
244353 usd
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
263020 usd
CY2024Q1 us-gaap Assets Current
AssetsCurrent
19744510 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
4991500 usd
CY2024Q1 us-gaap Other Receivables
OtherReceivables
2000000 usd
CY2023Q2 us-gaap Other Receivables
OtherReceivables
2000000 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
14791 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
101281 usd
CY2024Q1 us-gaap Assets Noncurrent
AssetsNoncurrent
2001000 usd
CY2023Q2 us-gaap Assets Noncurrent
AssetsNoncurrent
2116072 usd
CY2024Q1 us-gaap Assets
Assets
21745510 usd
CY2023Q2 us-gaap Assets
Assets
7107572 usd
CY2024Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
3704235 usd
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
5496629 usd
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3280365 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4911839 usd
CY2024Q1 us-gaap Notes Payable Current
NotesPayableCurrent
4478336 usd
CY2023Q2 us-gaap Notes Payable Current
NotesPayableCurrent
1484647 usd
CY2024Q1 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
3801381 usd
CY2023Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
10489606 usd
CY2023Q2 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
418455 usd
CY2024Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
159018 usd
CY2023Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
22971 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
16455600 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
23767491 usd
CY2024Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1244584 usd
CY2023Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1953842 usd
CY2024Q1 us-gaap Liabilities
Liabilities
17700184 usd
CY2023Q2 us-gaap Liabilities
Liabilities
25721333 usd
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20572447 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
20572447 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
338579 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
338579 shares
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
20572 usd
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
339 usd
CY2024Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
158449736 usd
CY2023Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
132993998 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-154607884 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-151750610 usd
CY2024Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
182902 usd
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
142512 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
4045326 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-18613761 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
21745510 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7107572 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7485708 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7632940 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2069559 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1605783 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
4653281 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
5254781 usd
CY2024Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
776844 usd
CY2023Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
535957 usd
us-gaap Gross Profit
GrossProfit
2832427 usd
us-gaap Gross Profit
GrossProfit
2378159 usd
CY2024Q1 us-gaap Gross Profit
GrossProfit
1292715 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
1069826 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1282965 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1374674 usd
CY2024Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
735575 usd
CY2023Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
270722 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6871647 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9560432 usd
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2750262 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1836083 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
65164 usd
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3638 usd
us-gaap Operating Expenses
OperatingExpenses
8154612 usd
us-gaap Operating Expenses
OperatingExpenses
11000270 usd
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
3485837 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
2110443 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-5322185 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-8622111 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-2193122 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1040617 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
846242 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
3145977 usd
CY2024Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
55980 usd
CY2023Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
273755 usd
CNXA Loss On Conversion Of Accounts Payable To Common Stock
LossOnConversionOfAccountsPayableToCommonStock
289980 usd
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
18523422 usd
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
3295687 usd
CY2024Q1 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
1578615 usd
CY2023Q1 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-3491910 usd
CNXA Derivative Expense
DerivativeExpense
14119784 usd
CNXA Derivative Expense
DerivativeExpense
8995962 usd
CY2024Q1 CNXA Derivative Expense
DerivativeExpense
2721195 usd
CY2023Q1 CNXA Derivative Expense
DerivativeExpense
1715557 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2464911 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-9671802 usd
CY2024Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1579506 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-5790155 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2857274 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-18293913 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3772628 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-6830772 usd
us-gaap Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax
-4461968 usd
CY2023Q1 us-gaap Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax
-635111 usd
us-gaap Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax
DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax
-41413892 usd
CY2023Q1 us-gaap Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax
DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax
-41413892 usd
us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
-45875860 usd
CY2023Q1 us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
-42049003 usd
CNXA Income Loss From Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2857274 usd
CNXA Income Loss From Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-64169773 usd
CY2024Q1 CNXA Income Loss From Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3772628 usd
CY2023Q1 CNXA Income Loss From Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-48879775 usd
us-gaap Net Income Loss
NetIncomeLoss
-2857274 usd
us-gaap Net Income Loss
NetIncomeLoss
-64169773 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-3772628 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-48879775 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
68318 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
13016 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
95338 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-158720 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2788956 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-64156757 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3677290 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-49038495 usd
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
23.13
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
23.13
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
70.11
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
70.11
CY2024Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
14.29
CY2024Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
14.29
CY2023Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
20.60
CY2023Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
20.60
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
175.82
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
175.82
CY2023Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
126.79
CY2023Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
126.79
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
23.13
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
23.13
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
245.94
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
245.94
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
14.29
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
14.29
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
147.39
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
147.39
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
693092 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
693092 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
260918 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
260918 shares
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
912147 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
912147 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
331631 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
331631 shares
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
32511932 usd
CY2022Q3 us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
14046300 usd
CY2022Q3 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
915545 usd
CY2022Q3 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
35250 usd
CY2022Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
4195000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
277625 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
58139 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-4266431 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
47773360 usd
CY2022Q4 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
277625 usd
CY2022Q4 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
113597 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-11023567 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
37141015 usd
CY2023Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
1836 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
191261 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-158720 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-48879775 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-11704383 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-18613761 usd
CY2023Q3 CNXA Stock Issued During Period Value Accounts Payable
StockIssuedDuringPeriodValueAccountsPayable
559980 usd
CY2023Q3 CNXA Stock Issued During Period Value Satisfaction Of Profit Guarantee On Note Payable
StockIssuedDuringPeriodValueSatisfactionOfProfitGuaranteeOnNotePayable
558294 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-27020 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-846765 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-18369272 usd
CY2023Q4 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
28062 usd
CY2023Q4 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
418455 usd
CY2023Q4 CNXA Stock Issued During Period Value Satisfaction Of Profit Guarantee On Note Payable
StockIssuedDuringPeriodValueSatisfactionOfProfitGuaranteeOnNotePayable
210801 usd
CY2023Q4 CNXA Reclassification Of Derivative Liability Upon Amendment Of Agreement
ReclassificationOfDerivativeLiabilityUponAmendmentOfAgreement
1456854 usd
CY2023Q4 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
95338 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
1762119 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-14397643 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-14397643 usd
CY2024Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
267896 usd
CY2024Q1 CNXA Cash Including Warrants
CashIncludingWarrants
17961828 usd
CY2024Q1 CNXA Stock Issued During Period Value Satisfaction Of Profit Guarantee On Note Payable
StockIssuedDuringPeriodValueSatisfactionOfProfitGuaranteeOnNotePayable
707954 usd
CY2024Q1 CNXA Reclassification Of Derivative Liability Upon Amendment Of Agreement
ReclassificationOfDerivativeLiabilityUponAmendmentOfAgreement
1118347 usd
CY2024Q1 CNXA Conversion Of Deferred Copensation To Warrants Equity
ConversionOfDeferredCopensationToWarrantsEquity
2187500 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-27928 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-3772628 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
4045326 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
4045326 usd
us-gaap Net Income Loss
NetIncomeLoss
-2857274 usd
us-gaap Net Income Loss
NetIncomeLoss
-64169773 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
115072 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
106199 usd
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
18523422 usd
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
3295687 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
295958 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
37086 usd
us-gaap Share Based Compensation
ShareBasedCompensation
746511 usd
us-gaap Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
-41413892 usd
CNXA Gain Loss On Derivative Expense
GainLossOnDerivativeExpense
14119784 usd
CNXA Gain Loss On Derivative Expense
GainLossOnDerivativeExpense
7280405 usd
CNXA Noncash Transaction Costs
NoncashTransactionCosts
85080 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
846242 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
3145977 usd
CNXA Settlement Expense
SettlementExpense
1477049 usd
CNXA Loss On Settlement Of Accounts Payable
LossOnSettlementOfAccountsPayable
289980 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-202308 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1502455 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1858755 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-3886603 usd
CNXA Increase Decrease In Prepaid Inventory
IncreaseDecreaseInPrepaidInventory
-296626 usd
CNXA Increase Decrease In Prepaid Inventory
IncreaseDecreaseInPrepaidInventory
424945 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-22972 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-37460 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-1935800 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-1361952 usd
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
954383 usd
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
320187 usd
us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
108828 usd
us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
50706635 usd
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-2748446 usd
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-13463138 usd
us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
6617328 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2748446 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6845810 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
17961828 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
9194882 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
3728000 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
1390000 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
710216 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
62434 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
1289939 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
4040676 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
19689673 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
6481772 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
49411 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
15786 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
16990638 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-348252 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
202095 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
665002 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
17192733 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
316750 usd
us-gaap Interest Paid Net
InterestPaidNet
706942 usd
us-gaap Interest Paid Net
InterestPaidNet
482687 usd
CNXA Conversion Of Convertible Notes Payable And Accrued Interest To Common Stock
ConversionOfConvertibleNotesPayableAndAccruedInterestToCommonStock
14046300 usd
CNXA Shares Issued For Contingent Consideration
SharesIssuedForContingentConsideration
418455 usd
CNXA Shares Issued For Contingent Consideration
SharesIssuedForContingentConsideration
915545 usd
CNXA Warrants Granted For Deferred Compensation
WarrantsGrantedForDeferredCompensation
2187500 usd
CNXA Derivative Liability Recorded For Shares And Warrants Issued In Private Placement
DerivativeLiabilityRecordedForSharesAndWarrantsIssuedInPrivatePlacement
4999882 usd
CNXA Note Receivable Issued In Sale Of Playsight
NoteReceivableIssuedInSaleOfPlaysight
2000000 usd
CY2022Q2 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1-for-10 reverse stock split
CY2024Q1 us-gaap Investments
Investments
16500000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
4045326 usd
CY2024Q1 us-gaap Investments
Investments
16500000 usd
CY2023Q4 CNXA Consulting Fees
ConsultingFees
127500 usd
CY2023Q4 CNXA Discretionary Compensation
DiscretionaryCompensation
127500 usd
CY2023Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
4972203 shares
CY2023Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.001
CY2023Q4 CNXA Bit Price
BitPrice
1.00
CY2023Q4 us-gaap Debt Instrument Convertible Threshold Consecutive Trading Days1
DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
30 integer
CY2023Q4 CNXA Bit Price
BitPrice
1.00
CY2024Q1 us-gaap Shares Issued
SharesIssued
200000 shares
CY2024Q1 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
200000 shares
CY2023Q4 CNXA Impact Of Israel And Hamas Conflict Description
ImpactOfIsraelAndHamasConflictDescription
the Central Bank of Israel announced its intent to sell up to $30 billion order to protect the New Israeli Shekel (“NIS”) from collapse, however despite the foregoing announcement the NIS weakened to approximately 3.92 NIS for one US dollar as of the same day. In addition, on October 9, 2023, the Tel Aviv-35 stock index of blue-chip companies dropped by 6.4% whereas the benchmark TA-125 index fell by 6.2%.
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-154607884 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84F_eus-gaap--UseOfEstimates_zsWe5OnWKsy3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86B_zAJqaDUtG8tj">Use of Estimates</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Accordingly, actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p id="xdx_840_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zWtPcuSp1JI6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_865_z4SpCEmwoKvj">Financial Statement Reclassification</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain prior year amounts within accounts payable, accrued expenses, and certain operating expenses have been reclassified for consistency with the current year presentation and had no effect on the Company’s balance sheet, net loss, shareholders’ deficit or cash flows.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
200000 usd
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
209690 usd
CY2024Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
884130 usd
CY2023Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
1509985 usd
CY2024Q1 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
700718 usd
CY2023Q2 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
1712553 usd
CY2024Q1 CNXA Capitalized Duty And Freight
CapitalizedDutyAndFreight
36628 usd
CY2023Q2 CNXA Capitalized Duty And Freight
CapitalizedDutyAndFreight
517228 usd
CY2024Q1 us-gaap Inventory Adjustments
InventoryAdjustments
290465 usd
CY2023Q2 us-gaap Inventory Adjustments
InventoryAdjustments
550000 usd
CY2024Q1 us-gaap Inventory Net
InventoryNet
1331011 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
3189766 usd
CY2024Q1 us-gaap Property Plant And Equipment Useful Life
PropertyPlantAndEquipmentUsefulLife
P5Y
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_84D_eus-gaap--ConcentrationRiskCreditRisk_zw6rZUYqqidc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86C_zLMAsJ7rXzrb">Concentration of Credit Risk</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company maintains its cash in bank deposit accounts, the balances of which at times may exceed insured limits. The Company continually monitors its banking relationships and consequently has not experienced any losses in such accounts. While we may be exposed to credit risk, we consider the risk remote and do not expect that any such risk would result in a significant effect on our results of operations or financial condition. See Note 4 for further details on the Company’s concentration of credit risk as well as other risks and uncertainties.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q1 us-gaap Derivative Instruments And Hedges Liabilities
DerivativeInstrumentsAndHedgesLiabilities
3801381 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
18802476 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1000 usd
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
100281 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
14791 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
0 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
4335 usd
CY2024Q1 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
1198357 usd
CY2023Q2 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
1535186 usd
CY2024Q1 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
864214 usd
CY2023Q2 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
1720606 usd
CY2024Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
35000 usd
CY2023Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
490424 usd
CY2024Q1 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
1182794 usd
CY2023Q2 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
1165623 usd
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3280365 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4911839 usd
CY2022Q2 us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
109737 shares
CY2022Q2 us-gaap Debt Conversion Converted Instrument Warrants Or Options Issued1
DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1
13200000 shares
CY2022Q2 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
846301 usd
CY2023Q1 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
122222 usd
CY2022Q1 us-gaap Business Combination Consideration Transferred Other1
BusinessCombinationConsiderationTransferredOther1
4000000 usd
CY2022Q1 CNXA Number Of Consigned Goods
NumberOfConsignedGoods
13000 integer
CY2023 CNXA Payments Of Related Party Debt
PaymentsOfRelatedPartyDebt
4000000 usd
CNXA Payments Of Related Party Debt
PaymentsOfRelatedPartyDebt
4000000 usd
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20572447 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
20572447 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
338579 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
338579 shares
CY2023Q3 us-gaap Shares Issued
SharesIssued
189718 shares
CY2023Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
188 usd
CY2023Q3 CNXA Stock Issued During Period Shares Issued Settlement Of Accounts Payable
StockIssuedDuringPeriodSharesIssuedSettlementOfAccountsPayable
67500 shares
CY2023Q3 CNXA Stock Issued During Period Shares Issued Settlement
StockIssuedDuringPeriodSharesIssuedSettlement
1350 shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
27000 shares
CY2023Q3 CNXA Stock Issued During Period Shares Issued Profit Guarantee On Note
StockIssuedDuringPeriodSharesIssuedProfitGuaranteeOnNote
93680 shares
CY2023Q4 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
1844506 shares
CY2023Q4 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
13707 shares
CY2023Q4 CNXA Stock Issued During Period Shares Issued For Contingent Consideration
StockIssuedDuringPeriodSharesIssuedForContingentConsideration
1964 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
1708152 shares
CY2023Q4 CNXA Stock Issued During Period Shares Issued Profit Guarantee On Note
StockIssuedDuringPeriodSharesIssuedProfitGuaranteeOnNote
85000 shares
CY2023Q4 us-gaap Stock Issued During Period Shares Reverse Stock Splits
StockIssuedDuringPeriodSharesReverseStockSplits
35683 shares
CY2023Q4 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1 for 40 reverse split
CY2023 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
151579 shares
CY2022Q2 us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
109737 shares
CY2022Q4 us-gaap Stock Issued During Period Shares Acquisitions
StockIssuedDuringPeriodSharesAcquisitions
48098 shares
CY2022Q4 us-gaap Stock Issued During Period Shares Acquisitions
StockIssuedDuringPeriodSharesAcquisitions
675 shares
CY2023Q1 us-gaap Stock Issued During Period Shares Acquisitions
StockIssuedDuringPeriodSharesAcquisitions
6993 shares
CY2023Q1 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
150 shares
us-gaap Payments For Rent
PaymentsForRent
6983 usd
us-gaap Payments For Rent
PaymentsForRent
9207 usd
CY2022Q1 CNXA Fair Value Of Common Stock
FairValueOfCommonStock
1334000 usd
CY2022Q2 us-gaap Stock Issued During Period Shares Acquisitions
StockIssuedDuringPeriodSharesAcquisitions
14960 shares
CY2023Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
418455 usd
CY2024Q1 us-gaap Cash
Cash
16500000 usd
CY2024Q1 us-gaap Stockholders Equity Period Increase Decrease
StockholdersEquityPeriodIncreaseDecrease
4045326 usd
CY2024Q1 us-gaap Investments
Investments
16500000 usd
CY2023Q4 CNXA Bit Price
BitPrice
1.00
CY2023Q4 us-gaap Debt Instrument Convertible Threshold Consecutive Trading Days1
DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
30 integer
CY2023Q4 CNXA Bit Price
BitPrice
1.00
CY2022Q4 us-gaap Cash
Cash
500000 usd
CY2022Q4 us-gaap Investments
Investments
500000 usd
us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
3954149 usd
us-gaap Disposal Group Including Discontinued Operation Operating Expense
DisposalGroupIncludingDiscontinuedOperationOperatingExpense
8416117 usd
CNXA Disposal Group Including Discontinued Operation Net Income Loss
DisposalGroupIncludingDiscontinuedOperationNetIncomeLoss
-4461968 usd

Files In Submission

Name View Source Status
cnxa-20240131_pre.xml Edgar Link unprocessable
0001493152-24-008851-index-headers.html Edgar Link pending
0001493152-24-008851-index.html Edgar Link pending
0001493152-24-008851.txt Edgar Link pending
0001493152-24-008851-xbrl.zip Edgar Link pending
cnxa-20240131.xsd Edgar Link pending
ex3-1.htm Edgar Link pending
ex3-1_001.jpg Edgar Link pending
ex3-1_002.jpg Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
cnxa-20240131_def.xml Edgar Link unprocessable
cnxa-20240131_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
cnxa-20240131_cal.xml Edgar Link unprocessable